INOInovio Pharmaceuticals, Inc.$0.74+10.24%
WAIT.
Not worth owning here — the balance sheet is under real strain and the filings carry red flags.
The balance-sheet safety score sits in its distress band and 2 accounting red flags are raised — the quality screen fails at any price. segment micro — there is no entry price on file yet.
QTick signal
-1net
1 bull / 1 bear factors · balancedBull 3 pts·Bear 4 pts30d
3 of 4 aligned — not yet
Quality fails the screen — a distress-zone balance sheet with forensic flags.
Market context—Sector read · not on fileRiskBalance sheet · Distress—PCE sensitivity · not on fileOKNot a falling knife
Chart pattern
Death cross
50d below 200d · bearish structure
Volume vs 20-day avg1.18× · 3.30M vs 2.78M avg
52-week range$0.56 – $2.98
Below high since 2015-99.8% · $386.12 high
Risk / reward—
Plan stop—
Max pain—
RSI 1433.5 washed out
Forensic flags2 review
What-if price
$0.74
$0.59 · -20.0%-20.0%move the price to stress-test the setupdrag to test another price+23.7% · $0.91+23.7%
Entry strategy · 10 triggers3 of 4 aligned — not yet
RSI 14✓
33.5
washed out
vs 50-day✓
$1.05
below the line
Bollinger●
$0.52
no lower pierce · fires below the slider range
VWAP 20✓
$0.74
below the rolling VWAP
Entry level●
—
not on file
Put wall●
—
not on file
MACD●
-0.02
below zero · rising toward the flip
RVolStatic
1.18×
below the 1.5× context threshold
Short int.Static
20.2%
20.2% of float short — crowded
ATRStatic
$0.09
14-session average true range
A checklist, not odds on a return: 3 of 4 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, relative volume and short interest are context only — they never count toward the total.
Next earnings
12 Aug 2026 · after the bell
amc · in 1 days
Next dividend
No indicated yield
no forward dividend on file